000 01213 a2200349 4500
005 20250513084445.0
264 0 _c19960307
008 199603s 0 0 eng d
022 _a0893-7648
024 7 _a10.1007/BF02740695
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCampbell, D B
245 0 0 _aThe use of toxicokinetics for the safety assessment of drugs acting in the brain.
_h[electronic resource]
260 _bMolecular neurobiology
_c
300 _a193-216 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBlood Proteins
_xmetabolism
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDrug Evaluation
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIntestinal Absorption
650 0 4 _aMale
650 0 4 _aN-Methyl-3,4-methylenedioxyamphetamine
_xpharmacokinetics
650 0 4 _aNeurotoxins
_xpharmacokinetics
650 0 4 _aPhenethylamines
_xpharmacokinetics
650 0 4 _aSex Characteristics
650 0 4 _aSpecies Specificity
773 0 _tMolecular neurobiology
_gvol. 11
_gno. 1-3
_gp. 193-216
856 4 0 _uhttps://doi.org/10.1007/BF02740695
_zAvailable from publisher's website
999 _c8561041
_d8561041